rs63749817
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_002087.4(GRN):c.708+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000499 in 1,604,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_002087.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- frontotemporal dementia and/or amyotrophic lateral sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neuronal ceroid lipofuscinosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- GRN-related frontotemporal lobar degeneration with Tdp43 inclusionsInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- neuronal ceroid lipofuscinosis 11Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GRN | NM_002087.4 | c.708+1G>A | splice_donor_variant, intron_variant | Intron 7 of 12 | ENST00000053867.8 | NP_002078.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GRN | ENST00000053867.8 | c.708+1G>A | splice_donor_variant, intron_variant | Intron 7 of 12 | 1 | NM_002087.4 | ENSP00000053867.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152214Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000799 AC: 2AN: 250468 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.00000413 AC: 6AN: 1451964Hom.: 0 Cov.: 32 AF XY: 0.00000692 AC XY: 5AN XY: 722952 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74350 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:3
- -
- -
Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 37120788, 23463024, 17030534, 30992141, 31914217, 28430294, 30054184, 28749476, 35752680) -
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions Pathogenic:3
- -
Criteria applied: PVS1,PS1,PS4_MOD -
- -
Frontotemporal dementia Pathogenic:1
- -
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;C3539123:Neuronal ceroid lipofuscinosis 11 Pathogenic:1
This sequence change affects a donor splice site in intron 7 of the GRN gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in GRN are known to be pathogenic (PMID: 16862116, 16950801, 22608501). This variant is present in population databases (rs63749817, gnomAD 0.009%). Disruption of this splice site has been observed in individuals with clinical features of frontotemporal dementia (PMID: 17030534, 23463024, 28430294, 28749476, 30054184, 30992141). ClinVar contains an entry for this variant (Variation ID: 203460). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at